The final analysis discusses the FDA 's decision not to exempt small entities from the rule because an exemption for small retailers would shift underage sales to those locations , lessening or eliminating the effectiveness and benefits of the access restrictions .
The analysis showed the FDA thought that overlooking small entities was morally wrong .